Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site pain, Malaise, Muscle contractions involuntary, Muscular weakness, Pyrexia
Clinical narrative: sudden onset of all skeletal muscles contraction lasting overnight; fever; pain in injection site; headache; change in urination pattern; dark urine; joint pain; loss of apetite; drastic transition from being a healthy person to a total wreck; it simply made me sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Jan2022 10:30 (Lot number: EJ3209) at the age of 62 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EJ3247, Location of injection: Arm Left, Vaccine Administration Time: 01:00 AM), administration date: 05Feb2021, when the patient was 61 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EJ1686, Location of injection: Arm Left, Vaccine Administration Time: 02:30 PM), administration date: 15Jan2021, when the patient was 61 years old, for Covid-19 immunization. The following information was reported: MUSCLE CONTRACTIONS INVOLUNTARY (non-serious) with onset 21Jan2022 21:00, outcome "recovering", described as "sudden onset of all skeletal muscles contraction lasting overnight"; PYREXIA (non-serious) with onset 21Jan2022 21:00, outcome "recovering", described as "fever"; VACCINATION SITE PAIN (non-serious) with onset 21Jan2022 21:00, outcome "recovering", described as "pain in injection site"; HEADACHE (non-serious) with onset 21Jan2022 21:00, outcome "recovering", described as "headache"; POLLAKIURIA (non-serious) with onset 21Jan2022 21:00, outcome "recovering", described as "change in urination pattern"; CHROMATURIA (non-serious) with onset 21Jan2022 21:00, outcome "recovering", described as "dark urine"; ARTHRALGIA (non-serious) with onset 21Jan2022 21:00, outcome "recovering", described as "joint pain"; DECREASED APPETITE (non-serious) with onset 21Jan2022 21:00, outcome "recovering", described as "loss of apetite"; GENERAL PHYSICAL HEALTH DETERIORATION (non-serious) with onset 21Jan2022 21:00, outcome "recovering", described as "drastic transition from being a healthy person to a total wreck"; ILLNESS (non-serious) with onset 21Jan2022 21:00, outcome "recovering", described as "it simply made me sick". Therapeutic measures were not taken as a result of muscle contractions involuntary, pyrexia, vaccination site pain, headache, pollakiuria, chromaturia, arthralgia, decreased appetite, general physical health deterioration, illness.  Additional information: With 10 hrs after the booster shot, a sudden onset of all skeletal muscles contraction lasting overnight, fever, pain in injection site, headache, change in urination pattern, dark urine, joint pain, loss of appetite, drastic transition from being a healthy person to a total wreck, it simply made me sick for the next 4 days. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.